FineMark National Bank & Trust - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 79 filers reported holding REVANCE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.25 and the average weighting 1.6%.

Quarter-by-quarter ownership
FineMark National Bank & Trust ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$35,000
-74.6%
1,700
-80.0%
0.00%
-80.0%
Q3 2016$138,000
+885.7%
8,500
+750.0%
0.02%
+650.0%
Q2 2016$14,000
-17.6%
1,0000.0%0.00%0.0%
Q1 2016$17,000
-50.0%
1,0000.0%0.00%
-50.0%
Q4 2015$34,000
-43.3%
1,000
-50.0%
0.00%
-50.0%
Q3 2015$60,000
-6.2%
2,0000.0%0.01%0.0%
Q2 2015$64,000
+56.1%
2,0000.0%0.01%
+33.3%
Q1 2015$41,000
+20.6%
2,0000.0%0.01%
+20.0%
Q4 2014$34,000
-12.8%
2,0000.0%0.01%
-16.7%
Q3 2014$39,0002,0000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders